Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma

Fig. 2

Kaplan–Meier curves of cumulative PFS in recurrent HCC patients; A, HAIC combined with TKIs and PD- 1 inhibitors versus TACE alone; B, TACE combined with TKIs and PD- 1 inhibitors versus TACE alone; C, HAIC combined with TKIs and PD- 1 inhibitors versus TACE combined with TKIs and PD- 1 inhibitors

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us